ABSTRACT
Objective
Methods
Results
Conclusion
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to UrologyReferences
- Prior authorizations for diagnostic skin biopsies: does anyone benefit?.JAMA Dermatol. 2017 Nov 1; 153 (PMID: 28973058): 1091-1092https://doi.org/10.1001/jamadermatol.2017.3516
- Prior authorization programs: a critical review of the literature.JMCP. 2001; 7: 297-303
American Medical Association. 2016 AMA Prior Authorization Physician Survey.https://www.ama-assn.org/sites/ama-assn.org/files/corp/media-browser/public/government/advocacy/2016-pa-survey-results.pdf. Published 2017. Accessed December 8, 2021.
- Impact of prior authorization of antiepileptic drugs in children with epilepsy.Pediatr Neurol. 2018 Jun; 83 (Epub 2018 Apr 3PMID: 29753573): 38-41https://doi.org/10.1016/j.pediatrneurol.2018.03.006
Cardiology Magazine. Barriers to new medications for cardiovascular disease: insights from CardioSurvey. https://www.acc.org/latest-in-cardiology/articles/2017/02/21/12/42/barriers-to-new-medications-for-cardiovascular-disease-insights-from-cardiosurve. Published 2017. Accessed November 5, 2021.
- Administrative burden and costs of prior authorizations in a dermatology department.JAMA Dermatol. 2020; 156: 1074-1078https://doi.org/10.1001/jamadermatol.2020.1852
- Exploratory Data Analysis.Addison-Wesley, 1977 (ISBN 0-201-07616-0)
Robeznieks, A. Prior Authorization is a major practice burden. How do you compare?.https://www.ama-assn.org/practice-management/sustainability/prior-authorization-major-practice-burden-how-do-you-compare. Published 2018. Accessed November 5, 2021.
American Medical Association. 2020 AMA prior authorization (PA) physician survey.https://www.ama-assn.org/system/files/2021-04/prior-authorization-survey.pdf. Published 2020. Accessed November 5, 2021.
- Prior authorization for medications in a breast oncology practice: navigation of a complex process.J Oncol Pract. 2017; 13: e273-e282https://doi.org/10.1200/JOP.2016.017756
- Treatment delays associated with prior authorization for infusible medications: a cohort study.Arthritis Care Res (Hoboken). 2020; 72 (PMID: 31507077PMCID: PMC7062557): 1543-1549https://doi.org/10.1002/acr.24062
- Treatment delays associated with prior authorization for infusible medications: a cohort study.Arthritis Care Res (Hoboken). 2020; 72 (PMID: 31507077PMCID: PMC7062557): 1543-1549https://doi.org/10.1002/acr.24062
- Increasing burden of prior authorizations in the delievery of oncology care in the United States.J Oncol Pract. 2018; 14 (Epub 2018 Aug 20): 525-528https://doi.org/10.1200/JOP.18.00428
- Evaluating the effect of prior authorizations in patients with complex dermatologic conditions.J Am Acad Dermatol. 2020; 83 (Epub 2020 Jul 2PMID: 32622138PMCID: PMC7936393): 1674-1680https://doi.org/10.1016/j.jaad.2020.06.998
American Medical Association. Health care coalition calls for prior authorization reform. https://www.ama-assn.org/press-center/press-releases/health-care-coalition-calls-prior-authorization-reform. Published 2017. Accessed November 5, 2021.
- Prior Authorization Takes its Toll on Urologists.Urology Times, MJH Life Sciences. 2019; (Accessed December 11, 2021)
Article info
Publication history
Footnotes
Financial Disclosure: The authors declare that they have no relevant financial interests.
Declarations of interest: The corresponding author, Vikas Bhatt, serves on the American Urologic Association resident and fellow advocacy work group.
